New Muscular Dystrophy Cooperative Research Centers announced

November 04, 2005

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Child Health and Human Development (NICHD), a part of the National Institutes of Health, have funded three new Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers focusing on this group of genetic muscle-wasting diseases. The late Senator Wellstone was a major champion of muscular dystrophy issues in the Congress.

The center at the University of Pennsylvania, co-directed by the university's H. Lee Sweeney, Ph.D., and Kathryn R. Wagner, M.D., Ph.D., of The Johns Hopkins School of Medicine, will explore new strategies for treating a variety of muscular dystrophies (MD). Two laboratory projects are focused on ways to increase muscle growth, and another on examining compounds that may be able to inhibit enzymes involved in breaking down muscle tissue. Clinical trials will determine the safety and feasibility of a potential drug treatment for Duchenne Muscular Dystrophy (DMD). The core facility--a muscle physiology lab--will analyze MD mouse models. Other sites involved with this center are the University of Florida, Gainesville, and the NINDS Intramural Research Program.

Center scientists at Washington, D.C.'s Children's National Medical Center, under the direction of Eric P. Hoffman, Ph.D., and Diana M. Escolar, M.D., will study biochemical pathways that contribute to DMD. A clinical project aims to identify genetic modifiers of the disease, and two laboratory studies focus on muscle cell damage and muscle growth and remodeling in mice. The center also has a bioinformatics and computing core, as well as a clinical core to help support the Cooperative International Neuromuscular Research Group, an existing consortium of MD clinical investigators. Collaborating with the center is the University of Padova in Italy.

The center at the University of Iowa, directed by the university's Kevin P. Campbell, Ph.D., and Steven A. Moore, M.D., Ph.D., will explore therapeutic strategies for different muscular dystrophies. One project focuses on muscle membrane maintenance and repair, and another on potential embryonic stem cell treatment in mice. A third study involves people with Fukutin Related Protein MD and the development of a mouse model for further investigation of this disease. The center cores here will serve as a national resource for human muscle biopsies, fibroblast cell cultures and embryonic stem cells for MD researchers, and will provide advanced services for diagnosing the different dystrophies.

These new centers join three others already funded by the National Institutes of Health and the Muscular Dystrophy Association at the University of Washington, the University of Pittsburgh and the University of Rochester. The centers spring from the Muscular Dystrophy Community Assistance, Research and Education (MD-CARE) Act passed by Congress in 2001. The centers work individually and collaboratively, and are guided by a steering committee that includes representatives from each center. Each has both basic and clinical research projects, and one or more core facilities to support them. Centers must also make core resources or services available to the national muscular dystrophy research community.

MD is characterized by progressive weakness and degeneration of the skeletal or voluntary muscles which control movement. Researchers at the Senator Paul D. Wellstone Centers study various forms of MD, including Duchenne/Becker Muscular Dystrophy, Myotonic Dystrophy, Facioscapulohumeral Dystrophy, Limb-Girdle Muscular Dystrophy, and others. MD can affect people of all ages. Although some forms first become apparent in infancy or childhood, others may not appear until middle age or later.
-end-
NIAMS, NINDS and NICHD are part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The mission of the NIAMS is to support research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. For more information about NIAMS, call the information clearinghouse at (301) 495-4484 or (877) 22-NIAMS (free call) or visit the NIAMS Web site at www.niams.nih.gov. The mission of the NINDS is to reduce the burden of neurological disease--a burden borne by every age group, by every segment of society, by people all over the world. For more information about NINDS, contact the Information Center at (800) 352-9424 or visit the NINDS Web site at www.ninds.nih.gov. The mission of the NICHD is to ensure that every person is born healthy and wanted, that women suffer no harmful effects from reproductive processes, and that all children have the chance to achieve their full potential for healthy and productive lives, free from disease or disability, and to ensure the health, productivity, independence, and well-being of all people through optimal rehabilitation. For more information about NICHD, call the Information Resource Center at (800) 370-2943 or visit the NICHD Web site at www.nichd.nih.gov.

NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases

Related Neurological Disorders Articles from Brightsurf:

Significant link found between air pollution and neurological disorders
Air pollution was significantly associated with an increased risk of hospital admissions for several neurological disorders, including Parkinson's disease, Alzheimer's disease, and other dementias, in a large, long-term study of US adults.

COVID-19 frequently causes neurological injuries
Without directly invading the brain or nerves, the virus responsible for COVID-19 causes potentially damaging neurological injuries in about one in seven infected, a new study shows.

Neurological consequences of COVID-19: The 'Silent Wave'
Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19?

New smart drug delivery system may help treatment for neurological disorders
A Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.

Roadmap for linking neurological and locomotor deficits
Scientists capture highly-detailed ''locomotor signatures'' of mouse models of neurological disease.

Scientists replace malfunctioning 'vacuum cleaner' cells linked to neurological disorders
Malfunctioning microglia are associated with a range of neurological diseases.

Exploring the neurological impact of air pollution
Air pollution has become a fact of modern life, with a majority of the global population facing chronic exposure.

Mole-rats' failure to social distance offers clue for treating some neurological disorders
A new study into why African naked mole-rats shun social distancing in favor of crowded sleeping arrangements provides insight into what may be occurring in the brains of people with certain neurological conditions, including autism spectrum disorder, epilepsy, and schizophrenia.

Maternal hypertensive disorders may lead to mental health disorders in children
Hypertensive pregnancy disorders, especially preeclampsia -- may increase the risk of psychological development disorders and behavioral and emotional disorders in children.

Probiotic intervention in ameliorating the altered CNS functions in neurological disorders
The review aims at giving a comprehensive analysis of the studies performed on animals and humans and discusses the findings in different neurological and psychiatric disorders (Anxiety, Major Depressive disorder, bipolar disorder, schizophrenia, autism spectrum disorder, cognitive impairments etc).

Read More: Neurological Disorders News and Neurological Disorders Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.